Ownership history in UBS Group AG · 24 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 89,887 | -1,096,294 | -92.4% | 0.00% | $9.6M | — |
| 2025 Q2 | ADDED | 1,186,181 | +923,327 | +351.3% | 0.02% | $112.2M | — |
| 2025 Q1 | REDUCED | 262,854 | -110,551 | -29.6% | 0.00% | $16.7M | — |
| 2024 Q4 | ADDED | 373,405 | +238,837 | +177.5% | 0.00% | $17.3M | — |
| 2024 Q3 | ADDED | 134,568 | +31,689 | +30.8% | 0.00% | $3.9M | — |
| 2024 Q2 | ADDED | 102,879 | +101,044 | +5506.5% | 0.00% | $1.5M | — |
| 2024 Q1 | REDUCED | 1,835 | -179 | -8.9% | 0.00% | $30K | — |
| 2023 Q4 | REDUCED | 2,014 | -1,323 | -39.6% | 0.00% | $40K | — |
| 2023 Q3 | ADDED | 3,337 | +332 | +11.0% | 0.00% | $54K | — |
| 2023 Q2 | REDUCED | 3,005 | -2,427 | -44.7% | 0.00% | $64K | — |
As of 2025 Q3 — sorted by position size